Enhancement of magnetocaloric effect by Nickel substitution in La0.67Ca0.33Mn0.98Ni0.02O3 manganite oxide von Laajimi, K., Khlifi, M., Hlil, E.K., Gazzah, M.H., Dhahri, J.

Volltext

A new range of specific perovskite-type materials with structural, magnetic and magnetocaloric properties: La0.67Ca0.33-xSrxMn0.98Fe0.02O3 (0.15 ≤ x ≤ 0.3) von Laajimi, K., Ayadi, F., Kchaw, M., Fourati, I., Khlifi, M., Gazzah, M.H., Dhahri, J., Juraszek, J.

Volltext

Enhancement of magnetocaloric effect by Nickel substitution in La 0.67 C a 0.33 Mn 0.98 Ni 0.02 O 3 manganite oxide von Laajimi, K., Khlifi, M., Hlil, E.K., Gazzah, M.H., Dhahri, J.

Volltext

Internal polarization electric field effects on the efficiency of InN/InxGa1-xN multiple quantum dot solar cells von El Aouami, A., Bikerouin, M., El-Yadri, M., Feddi, E., Dujardin, F., Courel, M., Chouchen, B., Gazzah, M.H., Belmabrouk, H.

Volltext

Internal polarization electric field effects on the efficiency of InN/In x Ga 1 - x N multiple quantum dot solar cells von El Aouami, A., Bikerouin, M., El-Yadri, M., Feddi, E., Dujardin, F., Courel, M., Chouchen, B., Gazzah, M.H., Belmabrouk, H.

Volltext

A new range of specific perovskite-type materials with structural, magnetic and magnetocaloric properties: La0.67Ca0.33-Sr Mn0.98Fe0.02O3 (0.15 ≤ x ≤ 0.3) von Laajimi, K., Ayadi, F., Kchaw, M., Fourati, I., Khlifi, M., Gazzah, M.H., Dhahri, J., Juraszek, J.

Volltext

Back doping design in delta-doped AlGaN/GaN heterostructure field-effect transistors von Saidi, I., Bouzaïene, L., Gazzah, M.H., Mejri, H., Maaref, H.

Volltext

A numerical study of the supply mode effects on high-pressure mercury discharge lamp dynamic thermal behavior von Kaziz, S., Ahmed, R. Ben, Araoud, Z., Gazzah, M. H., Charrada, K., Said, R.

Volltext

First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848) von Gazzah, A, Stjepanovic, N, Ryu, M.H, Tabernero, J, Soria, J.C, Bedard, P, Kang, Y.K, Bahleda, R, Guillemin-Paveau, H, Henry, C, Hatteville, L, Zilocchi, C, Demers, B, Hierro, C

Volltext

23 - First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848) von Gazzah, A., Stjepanovic, N., Ryu, M.H., Tabernero, J., Soria, J.C., Bedard, P., Kang, Y.K., Bahleda, R., Guillemin-Paveau, H., Henry, C., Hatteville, L., Zilocchi, C., Demers, B., Hierro, C.

Volltext